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ABSTRACT   
Multi-spectral spatially modulated light is used to guide localized spectroscopy of surgically resected tissues for cancer 
involvement.  Modulated imaging rapidly quantifies near-infrared optical parameters with sub-millimeter resolution over 
the entire field for identification of residual disease in resected tissues.  Suspicious lesions are further evaluated using a 
spectroscopy platform designed to image thick tissue samples at a spatial resolution sensitive to the diagnostic gold 
standard, pathology.  MI employs a spatial frequency domain sampling and model-based analysis of the spatial 
modulation transfer function to interpret a tissue’s absorption and scattering parameters at depth.  The spectroscopy 
platform employs a scanning-beam, telecentric dark-field illumination and confocal detection to image fields up to 1cm2 
with a broadband source (480:750nm).  The sampling spot size (100µm lateral resolution) confines the volume of tissue 
probed to within a few transport pathlengths so that multiple-scattering effects are minimized and simple empirical 
models may be used to analyze spectra. Localized spectroscopy of Intralipid and hemoglobin phantoms demonstrate 
insensitivity of recovered scattering parameters to changes in absorption, but a non-linear dependence of scattering 
power on Intralipid concentration is observed due to the phase sensitivity of the measurement system. Both systems were 
validated independently in phantom and murine studies.  Ongoing work focuses on assessing the combined utility of 
these systems to identify cancer involvement in vitro, particularly in the margins of resected breast tumors.   
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1. INTRODUCTION  
Breast conserving therapy (BCT), which includes local excision and radiation treatment to the breast, has been the 
standard of care for early breast cancers (Stage 0-II), since five major prospective, randomized trials in North American 
and Europe demonstrated that the long-term survival after BCT is equivalent to that of radical mastectomy for most 
patients when surgical margins are clear of residual disease1-5. Most of the 250,000 women annually diagnosed with 
breast cancer are eligible for BCT, resulting in approximately 165,000-180,000 conservative surgeries each year6.  
Following breast conservation, the strongest risk factor for local recurrence and mortality is a positive resection margin 
(tumor cells on ink).  Therefore, if a margin is positive or close (cancer present within 1-2mm of margin surface), the 
patient is advised to undergo re-excision surgery to achieve clear margins7, 8. Margin status is currently evaluated post-
operatively by microscopic evaluation of pathology in small, representative pieces of tissue. While sampled tissues are 
adequate for assessing tumor type, grade and receptor status, they are insufficient for evaluating important prognostic 
factors like disease extent, multi-focality and heterogeneity.  
 
The fundamental challenge encountered when applying spectral techniques to margin assessment is the need for 
microscopic resolution over a wide field.  Techniques that probe large volumes of tissue rely on the assumption that 
ultra-structural malignant transformations provide disease-specific contrast in volume-averaged measures, but breast 
tissue is markedly heterogeneous, which makes distinguishing small foci of cancer within the spectrum of normal tissue 
challenging9-11. Most spectral tools developed for margin assessment involve fiber bundles that cannot sample the full 
tissue field at a resolution sufficient to account for specimen heterogeneity12, 13. So while spectroscopy methods like 
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fluorescence, diffuse reflectance and Raman spectroscopy are responsive to the tissue’s biochemical and ultra-structural 
state14-18; these techniques minimally sample tissue pathology.  
 
A broadband spectroscopy platform was developed to image thick tissue samples at a resolution sensitive to the 
diagnostic gold standard, pathology19. Tissue samples were raster-scanned across a static beam using a motorized stage 
and the sampling spot size (100µm lateral resolution) confined the volume of tissue probed to within a few transport 
pathlengths so that multiple-scattering effects were minimized and simple empirical models parameterized the spectra.  
A k-Nearest Neighbor (k-NN) classifier was trained using parameters extracted from the localized scattering spectrum, 
automating diagnosis of benign and malignant breast pathologies in situ with a sensitivity and specificity of 91% and 
77% respectively.  Performance of the classifier was validated in 67,000 spectra from 29 excised breast tissues20.  This 
initial study characterized the spectral response of breast pathologies, but the system’s utility was limited by its long data 
acquisition times and restricted sampling field.  
 
Data acquisition times have been improved via development of a dark-field in situ scanning-beam spectroscopy platform 
that rapidly sample fields up to 1cm2.  Nonetheless, candidates for BCT may have tumors up to 5cm in diameter and 
spectral analysis of the full tumor field is not feasible. To overcome the fundamental tradeoff between microscopic 
resolution and field side, a multi-modal approach was employed.  Modulated imaging (MI), a non-contact and non-
scanning technique that rapidly samples wide-field optical properties at sub-millimeter resolution, was used to guide 
dense spectral sampling using the scanning-beam spectroscopy platform21. Scanned ROI are then correlated with 





Figure 1 Schematic of the optical assessment methodology: (a) sample full-field optical parameters with modulated imaging, 
(b) broadband spectroscopy in suspicious ROI, (c) classify spectral parameters according to pathology diagnosis. 
2.1 Multi-spectral spatially modulated light to guide spectroscopy 
Modulated imaging (MI) employs spatial frequency domain sampling and model-based analysis of the spatial 
modulation transfer function (s-MTF) to interpret a tissue’s optical properties at depth. A compact modulated imaging 
system was purchased from Modulated Imaging Inc., to map a tissue’s absorption and scattering parameters at depth 
using spatially modulated plane wave projections in the NIR (658, 730, 850, 970nm).  System specifications and theory 
are detailed in the references 22, 23.  
Sinusoidal patterns of varying spatial frequency are projected onto the sample using a projection system and digital 
micro-mirror device. A one-dimensional modulation is generated in the x-direction to simplify the homogenous model of 
diffuse reflectance and a 16-bit CCD camera captures the diffusely reflected photons. Specular reflections are minimized 
by illuminating at a small angle to normal incidence and by using crossed linear polarizers. Each spatial frequency is 
projected at three phase angles for amplitude demodulation of the AC and DC signals24.  A Siloxane TiO2 reflectance 
standard is used to calibrate for intensity fluctuations and spatial non-uniformity in the illumination and imaging 
systems.  Each spatial frequency projection is repeated at four NIR wavelengths using high power LED sources (658, 
730, 850 and 970nm) and interference filters are employed to constrain the detection waveband.  Diffuse reflectance is 
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mapped as a function of frequency using the spatial Fourier transform of modulated images obtained at varying spatial 
frequencies. The steady state diffusion equation reduces to a second-order Helmholtz equation for fluence as a function 
of depth when assuming a sinusoidal source incident upon a homogenous, linear media22.  Multi-spectral measures allow 
the use of a power law modified by Beer’s law to fit for the reduced scattering coefficient and chromophore 
concentrations. The near-infrared wavelengths enable quantification of the concentrations of oxygenated and 
deoxygenated hemoglobin, water, adipose and cellular scattering.  Optical properties are recovered using a rapid two-
frequency look up table (LUT), constructed using cubic spline interpolation of the forward-model data at two 
frequencies. 
 
2.2 Scanning-beam broadband spectroscopy in suspicious ROI 
Suspicious lesions identified by MI parameter maps are imaged at a higher resolution using the scanning-beam 
spectroscopy platform.  Its illumination and detection spot size is laterally constrained to 100μm, minimizing multiple-
scattering effects so that simple empirical models may be used to parameterize the spectra.  Full spectra are acquired at 
each 100μm-diameter pixel for thick tissue samples in a 1cm2 field.  The spectroscopy platform is detailed in the 
reference21.  It combines a broadband telecentric scanning design with dark-field illumination/detection for efficient 
rejection of specular light, while maintaining a consistent sampling geometry across the image field.  A tungsten halogen 
lamp is used as the source (480:750nm) with an exposure time of 300ms for pancreas tissues. Tissue acquisition took 
approximately 40min, during which time the tissue was hydrated with phosphate buffer saline.  Much faster exposure 
times are possible with a broadband super continuum laser source, which is currently being integrated into the system.  
All measures are background subtracted and referenced to gray Spectralon (Labsphere Inc) on a point-by-point basis.  
An empirical approximation to Mie theory modified by a Beer-Lambert attenuation factor to account for local absorption 
by chromophores was sufficient to parameterize spectra20.   
Rλ = A[ fλ
−b + (1− f )λ−4 )]exp−Γλ [ HbT ]( fSO2ε HbO2,λ +(1− fSO2 )ε Hb ,λ )  
Here, the wavelength-dependence of the reduced scattering coefficient is described by a combination of Rayleigh and 
Mie theory. A , b and f are the scattering amplitude, scattering power, and Mie contribution to scatter respectively.  
The scattered reflectance is exponentially attenuated due to chromophore absorption.  The absorption coefficient is 
defined as the product of each chromophore concentration with its wavelength-dependent molar extinction coefficient.  
The primary tissue absorbers in the 480-750nm waveband are oxygenated and deoxygenated hemoglobin.  Their 
concentrations are coupled by the parameters:  total hemoglobin, [HbT] and the oxygen saturation factor, fSO2 .  The 
molar extinction spectra of these chromophores are given by εHbO2 (λ)  and εHb (λ)  respectively 
25. Γλ  represents the 
mean optical pathlengths, which depends on both the measurement geometry and the absorption and scattering 
properties of the tissue.   Scanned ROI are then correlated with the diagnostic gold standard, pathology, to assess the 
ability of these tools to assess the tissue’s disease state. 
3. DATA 
3.1 Phantom Data 
A series of Intralipid and hemoglobin phantoms were imaged to characterize the spectroscopy system’s response to 
changes in absorption and scattering. A series of scattering phantoms with [5 4 3 2 1 0.5] % Intralipid were serially 
diluted with porcine blood, with a maximum concentration of 30uM hemoglobin.  All measures were background 
subtracted and referenced to 5% Intralipid on a point-by-point basis.  The exposure time was 100ms. Figure 2(a) shows 
the nonlinear relationship between the calculated26 and recovered reduced scattering coefficient for varying 
concentrations of hemoglobin. Recovered scattering parameters are independent to changes in absorption, but a 
nonlinear dependence on scatterer concentration is observed due to the phase sensitivity of the measurement system. 
Figure 2(b) shows the recovered product of total hemoglobin concentration and transport path length, as a function of 
true hemoglobin concentration, at the five concentrations of Intralipid. The box and whisker plots illustrate the spread in 
recovered absorption parameter for all concentrations of Intralipid.    
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Figure 2  (a) Calculated vs. recovered reduced scattering coefficient as a function of variation in total hemoglobin and 
Intralipid concentration; (b) recovered path length times total hemoglobin as a function of total hemoglobin concentration.  
Box and whisker plots indicate variation in recovered values from Intralipid concentrations varying from 0.5 to 5%. 
Similarly, phantom studies are being used to characterize the spectral response of the modulated imaging system.  
3.2 Tissue Data 
To assess the combined use of modulated imaging and the scanning beam spectroscopy platform to characterize the 
pathology of excised tissues, four normal pancreas and four pancreas tumors mouse were imaged in a murine model in 
vitro.  The tissue was hydrated with a phosphate buffer solution and imaged immediately after excision. Figure 3(a-c) 
shows the optical maps of a murine pancreas on a diffusive background generated by modulated imaging.  A suspicious 
region of interest is highlighted in blue.  Figure 3(d) shows the parameter maps generated by the scanning-beam 
spectroscopy platform within the suspicious field of view and Figure 3(e) shows its corresponding pathology.   
 
Figure 3 (a) Scattering power, (b) log of the scattering amplitude and (c) total hemoglobin recovered by the modulated 
imaging system. (d) Optical maps generated by the scanning beam spectroscopy platform with a digital photograph of the 
tissue ROI in its upper left corner;  (e) corresponding histology. 
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Optical maps were correlated to pathology and the spectral response of normal, tumor and necrotic pathologies were 
assessed.  Correlation with microscopic features was not possible because the histopatholopic processing of the murine 
tissues resulted in severe artifacts that limited co-registration between pathology and recovered optical maps.  In the 
future, inked pins will be used to mark imaged fields of view to improve co-registration.  
4. RESULTS 
Figure 4(a) shows the spectral response of normal, tumor and necrotic tissue in the murine pancreas. Greater scattering 
slope is observed in the tumor and necrotic pathologies as compared to normal pathologies. Figure 4(b-d) illustrates 
clustering of the spectral remission parameters for all pixels according to pathologic diagnosis.   
 
Figure 4 (a) Spectral response of normal, tumor and necrotic pathologies. (b-d) Two-dimensional scattering plots of the 
recovered optical parameters.  Average scattering irradiance is not displayed because it demonstrates the same trend as the 
scattering amplitude. 
This type of dataset may be used to train a classification algorithm to identify pathologies based spectral features, as 
demonstrated previously using breast tissues20. Only the scattering power distribution was normal as determined by 
looking at the normal data probability plot for all parameters and diagnostic categories. Normality is expected to 
improve with increasing sample size.  A Kruskal-Wallis test was used to compare the medians for each parameter 
distribution according to diagnostic category. Figure 5(a-d) illustrates box plots of each parameter distribution according 
to diagnosis. 
Proc. of SPIE Vol. 7907  79070P-5




Figure 5 (a) distribution of recovered hemoglobin values, (b) scattering amplitude, (c) scattering power and (d) average 
scattering irradiance for all diagnostic categories.  p-values for all approached 0, indicating a statistically significant difference 
between the medians of the distributions. 
The computed p-values were all much less than 0.05, indicating that the sample medians are significantly different. 
5. CONCLUSIONS 
Breast tissue is markedly heterogeneous, therefore wide field of view imaging is necessary to assess disease extent.  
Additionally, localized spectroscopy is needed to identify small foci of cancer within a heterogeneous background and to 
correlate measures with the diagnostic gold standard, pathology.  The proposed methodology uses NIR spatially 
modulated light to guide localized spectroscopy of excised tissues.  The modulated imaging system samples the full 
tissue field, rapidly, in a non-contact and non-scanning way.  The scanning-beam spectroscopy platform rapidly raster-
scans thick tissue samples in 1cm2 suspicious fields of view, recovering broadband spectra from each 100-micron 
diameter pixel.  The systems have been validated independently and this multi-modal methodology was assessed in 
murine studies.  Future work involves assessment of the combined utility of the systems identify residual cancer in 
resected breast tissues.   
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